Get our Free Patent Expiration Newsletter

Serving hundreds of leading biopharmaceutical companies globally:

Julphar
Citi
Fuji
Accenture
Covington
Queensland Health

Generated: September 16, 2019

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR AMINOLEVULINIC ACID HYDROCHLORIDE

  Try a free trial


See Plans and Pricing

« Back to Dashboard

Clinical Trials for Aminolevulinic Acid Hydrochloride

Trial ID Title Status Sponsor Phase Summary
NCT00002963 Photodynamic Therapy in Treating Patients With Skin Cancer Completed Roswell Park Cancer Institute Phase 2 RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid cream may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodynamic therapy works in treating patients with skin cancer.
NCT00002975 Photodynamic Therapy in Treating Patients With Skin Cancer Completed National Cancer Institute (NCI) Phase 2 RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodynamic therapy that includes aminolevulinic acid works in treating patients with skin cancer.
NCT00002975 Photodynamic Therapy in Treating Patients With Skin Cancer Completed Roswell Park Cancer Institute Phase 2 RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to light to kill tumor cells. Photodynamic therapy using aminolevulinic acid may be effective in treating patients with skin cancer. PURPOSE: This randomized phase II trial is studying how well photodynamic therapy that includes aminolevulinic acid works in treating patients with skin cancer.
>Trial ID >Title >Status >Phase >Summary

Subscribe to access the full database, or try a Free Trial

Clinical Trial Conditions for Aminolevulinic Acid Hydrochloride

Condition Name

Condition Name for Aminolevulinic Acid Hydrochloride
Intervention Trials
Actinic Keratosis 11
Actinic Keratoses 8
Glioblastoma 5
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Condition MeSH

Condition MeSH for Aminolevulinic Acid Hydrochloride
Intervention Trials
Keratosis, Actinic 24
Keratosis 24
Glioma 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Locations for Aminolevulinic Acid Hydrochloride

Trials by Country

Trials by Country for Aminolevulinic Acid Hydrochloride
Location Trials
United States 84
Finland 4
Japan 2
Netherlands 2
China 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Trials by US State

Trials by US State for Aminolevulinic Acid Hydrochloride
Location Trials
California 12
New York 8
Illinois 7
Ohio 6
Texas 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Progress for Aminolevulinic Acid Hydrochloride

Clinical Trial Phase

Clinical Trial Phase for Aminolevulinic Acid Hydrochloride
Clinical Trial Phase Trials
Phase 4 10
Phase 3 9
Phase 2 23
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Status

Clinical Trial Status for Aminolevulinic Acid Hydrochloride
Clinical Trial Phase Trials
Completed 23
Recruiting 15
Not yet recruiting 10
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Clinical Trial Sponsors for Aminolevulinic Acid Hydrochloride

Sponsor Name

Sponsor Name for Aminolevulinic Acid Hydrochloride
Sponsor Trials
DUSA Pharmaceuticals, Inc. 12
National Cancer Institute (NCI) 12
Joint Authority for Päijät-Häme Social and Health Care 4
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Sponsor Type

Sponsor Type for Aminolevulinic Acid Hydrochloride
Sponsor Trials
Other 87
Industry 21
NIH 13
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

Harvard Business School
UBS
Boehringer Ingelheim
Daiichi Sankyo
Fish and Richardson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.